维普中文期刊产品整合服务
50篇 您的检索式:作者名="BLOIS A"
    题名 作者 年代 出处 被引量
1In vitro modulation of protective antibody responses by estrogen,progesterone and interleukin-6显示文摘Canellada A Blois S Gentile T 2002Am J Reprod Immunol2002,48,:1
2Efficient in vivo vascularization of tissue-engineering scaffolds 显示文摘Hegen A Blois A Tiron CE 2011J Tissue Eng Regen Med2011,5,4:1
3The chromogranin A peptide vasostatin- I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells 显示文摘Blois A Srebro B Mandala M 2006Regul Pept2006,135,12:1
4Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications 显示文摘Buque A Bloy N Aranda F 2015Oncoimmunology2015,4,10:1
5Electron spin resonance studies on melanin 显示文摘Blois M S Zahlan A B Maling J E 1964Biophysical Journal1964,4,:1
6Murine abortion isassociated with enhanced interleukin -6 levels at the fetomaternal interface 显示文摘Zenclussen A C Blois S Stump O R 2003Cytokine2003,24,4:1
7Evidence for a Structurally Homologous Rh -like Polypeptide in Rhnu Erythrocytes显示文摘SCHROIT A J BLOY C CONNOR J 1990Biochemistry1990,29,25:1
8The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells显示文摘Blois A Srebro B Mandala M 0,,1:1
9Murine abortion is associated with enhanced interleukin-6 levels at the fetomaternal interface显示文摘Zenclussen A C Blois S Stumpo R 2003Cytokine2003,24,4:1
10The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells 显示文摘Blois A Srebro B Mandala M 2006Regul Pept2006,135,12:1
11The role of RNA pseudoknot stem 1 length in the promotion of efficient-1 ribosomal frameshifting显示文摘Npthine S Liphardt J Bloys A 1999J Mol Biol1999,288,:1
12Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine,phosphatidylcholine and phosphatidylethanolamine显示文摘Blois A Holmsen H Martino G 0,,1:1
13Aerodynamic characteristics of an aerofoil with small trailing edge flaps 显示文摘Durrant Bloy A W 1995Wind Engineering1995,19,3:1
1468Ga -labeled DOTA - peptides and 68 Ga - labeled radiopharraaceuticals for positron emission tomography : current status of research, clinical applications, and future perspectives显示文摘Breeman W A de Blois E Sze C H 2011Semin Nucl Med2011,41,4:1
15Efficient in vivo vascularization of tissue-engineering scaffolds显示文摘Hegen A Blois A Tiron CE 2011J Tissue Eng Regen Med2011,5,4:1
16Enhanced aerofoil per- formance using small trailing-edge flaps显示文摘Bloy A W Tsioumanis N Mellor N T 1997Journal of Aircraft1997,34,4:1
17Interactions of ch-romogranin A-derived vasostatins and monolyers of phosphatidylser-ine, phosphatidylcholine and phosphatidylethanolamine 显示文摘Blois A Holmsen H Martino G 2006Regul Pept2006,134,1:1
18Study of low-fre- quency noise performance of nanobridge-based SQUIDs in external magnetic fields显示文摘Rozhko S Hino T Blois A etal 2013IEEE Trans- actions on Applied Superconductivity2013,23,3:1
19The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells 显示文摘Blois A Srebro B Mandala M 2006Regul Pept2006,135,12:1
20Structure of the human telomerase RNA pseudoknot reveals conserved tertiary interactions essential for function 显示文摘Theimer C A Blois C A Feigon J 2005Molecular Cell2005,17,5:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费